Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.

People with insomnia and concomitant obstructive sleep apnea (OSA) represented a fairly common, medically complex group for ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

Medicare and Social Security go-broke dates pushed up due to rising health care costs, new SSA law BY Associated Press Washington, D.C. UPDATED 5:08 PM ET Jun. 20, 2025 ...

Having five to 14 such events per hour classifies you as having mild sleep apnea. When this goes up to 15 to 29, it’s moderate sleep apnea. The severe range is 30 or more such events per hour.

IQVIA figures on prescriptions for Zepbound and Wegovy, reported by Reuters, suggest that there were nearly 339,000 scrips for Lilly's product in the week ending 18th April, overtaking Novo ...

In 2025, the Part A deductible is $1,676, which you must meet before Medicare covers eligible costs. They will then cover eligible costs in full for up to 60 days.

Personally, I've been on Zepbound for nearly 10 weeks now and I've lost over 25 pounds thanks to a combination of the injection, diet, exercise and, of course, the advice of my doctor.

Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand Mounjaro in the last three months of the year, although, they still ...